◆英語タイトル:Green Cross Cell Corp (031390) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011928
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月13日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Green Cross Cell Corp (Green Cross Cell), formerly Innocell Corp, a subsidiary of Green Cross Corp, is a provider of immunotherapeutics for the treatment of cancer. The company offers Immuncell-LC, an anti-cancer immune therapeutic that is derived from lymphocytes of cancer patient. It offers cryopreservation of cord blood Cord blood that contains stem cells, which can be used to treat various diseases such as pediatric cancer, leukemia, stroke, diabetes, and liver diseases, among others. Green Cross Cell offers contract services ranging from manufacturing of the biopharmaceuticals, processing, cell storage, and consulting, to the product delivery. The company also carries out research programs targeted at the treatment of leukemia, pancreatic cancer, ovarian cancer, acquired immunodeficiency syndrome (AIDS) and glioblastoma. Green Cross Cell is headquartered in Seoul, South Korea.
Green Cross Cell Corp (031390) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Green Cross Cell Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Green Cross Cell Corp, Medical Devices Deals, 2011 to YTD 2017 9
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
AroCell Enters into Co-Development Agreement with Green Cross Cell 11
Green Cross Cell and ToolGen to Enter into Partnership 12
Equity Offering 13
Innocell Completes Private Placement Of Shares For US$13 Million 13
Debt Offering 14
Green Cross Cell Raises USD55.3 Million in Private Placement of Convertible Bonds 14
Green Cross Cell Corp – Key Competitors 15
Green Cross Cell Corp – Key Employees 16
Green Cross Cell Corp – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Strategy And Business Planning 18
Sep 14, 2017: Green Cross Cell, Maryland agree to expand the cooperation between the biohealth and life science sectors 18
Legal and Regulatory 19
Aug 30, 2017: Green Cross Cell: Acquisition of INNO-BIZ certification 19
Product News 20
Apr 14, 2017: Green Cross Cell, the launch of a colorectal cancer clinical trial 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21
List of Tables
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Green Cross Cell Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Green Cross Cell Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Green Cross Cell Corp, Medical Devices Deals, 2011 to YTD 2017 9
Green Cross Cell Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
AroCell Enters into Co-Development Agreement with Green Cross Cell 11
Green Cross Cell and ToolGen to Enter into Partnership 12
Innocell Completes Private Placement Of Shares For US$13 Million 13
Green Cross Cell Raises USD55.3 Million in Private Placement of Convertible Bonds 14
Green Cross Cell Corp, Key Competitors 15
Green Cross Cell Corp, Key Employees 16